Qualitek LabsBOM:544091 -2.03%54 ROE % is 13.33% as of Mar. 2026, which is 34% below its 10-year median of 20.34. GuruFocus rates BOM:544091 with a GF Score™ of 54/100. The stock has 5 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, Qualitek Labs ranks better than 79.21% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Qualitek Labs's annualized net income for the quarter that ended in Mar. 2026 was ₹197 Mil. Qualitek Labs's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ₹1,475 Mil. Therefore, Qualitek Labs's annualized ROE % for the quarter that ended in Mar. 2026 was 13.33%.
The historical rank and industry rank for Qualitek Labs's ROE % or its related term are showing as below:
BOM:544091'
s ROE % Range Over the Past 10 Years
Min: 10.57 Med: 20.34 Max: 246.22
Current: 11.47
During the past 6 years, Qualitek Labs's highest ROE % was 246.22%. The lowest was 10.57%. And the median was 20.34%.
BOM:544091's ROE % is ranked better than 79.21% of 202
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.31
vs BOM:544091: 11.47
Qualitek Labs (BOM:544091) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Qualitek Labs ROE % Related Terms
Qualitek Labs ROE % Historical Data
* Premium members only.
The historical data trend for Qualitek Labs's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Qualitek Labs's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qualitek Labs ROE % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Qualitek Labs's ROE % distribution charts can be found below:
* The bar in red indicates where Qualitek Labs's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Qualitek Labs (BOM:544091) has a ROE % of 13.33% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Qualitek Labs and its competitors. This is 34% below median its historical median of 20.34. Over the past decade, Qualitek Labs' ROE % has ranged from 10.57 to 246.22. According to the industry distribution chart, Qualitek Labs ranks #42 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 20.8%.
Is Qualitek Labs' ROE % too high?
Qualitek Labs' current ROE % of 13.33% is 34% below median its 10-year median of 20.34. Over the past 10 years, this metric has ranged from a low of 10.57 to a high of 246.22. Based on the distribution chart, Qualitek Labs ranks #42 out of 202 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Qualitek Labs has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Qualitek Labs' ROE % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Qualitek Labs ranks #42 out of 202 companies for ROE %. This places Qualitek Labs in the top 21% of its industry — outperforming the majority of peers. Historically, Qualitek Labs' own ROE % has ranged from 10.57 to 246.22 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Diagnostics & Research company?
A good ROE % depends on the Medical Diagnostics & Research industry context. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Qualitek Labs and its competitors. Qualitek Labs's current ROE % is 13.33%, which is 34% below median its own 10-year median of 20.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qualitek Labs stock overvalued right now?
Qualitek Labs (BOM:544091) has a current ROE % of 13.33%. The current ROE % is 13.33%, which is 34% below median its 10-year median of 20.34. Qualitek Labs' overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Qualitek Labs (BOM:544091), the current ROE % is 13.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Qualitek Labs Ltd is engaged in the business of providing testing, inspection, homologation, certification, and consultancy services to various industries such as automotive, defence, metals & metallurgy, environment and water, minerals, food & agriculture, pharma & healthcare.
54GF Score
Get the complete analysis for BOM:544091
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544091 has been successfully added to your 
